Kaklamani Speaks to a Shifting HER2+ Breast Cancer Paradigm

Season 5 Episode 10  ·  May 24, 2021, 07:44 PM
Headliner
Share
Subscribe

In our exclusive interview, Kaklamani discussed current treatment sequencing approaches in HER2-positive breast cancer and the benefits and challenges of moving effective treatments in earlier lines of therapy.

Share
Subscribe
Next
Baumann Characterizes the Current Treatment Landscape of Merkel Cell Carcinoma
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air